Healthy Volunteers for New Drug Being Developed for The Treatment of Certain Types of Cancer
The purpose of this study is to compare how much of the study drug gets into the bloodstream and how long it takes the body to get rid of it, and to evaluate the safety and tolerability of the study drug, when given by vial and syringe versus an injector pen.
- Apr. 18 – 26, 2023
Study involves 1 stay of 4 nights and 1 follow-up call.
- Check-in: April 18
- Check-out: April 22
- Follow-up Call: April 26
- Check-in: May 1
- Check-out: May 5
- Follow-up Call: May 9
- Compensation up to $3,150 may be provided for time and participation
- Healthy Non-smoking Adults
- Age 18-55
- Body Mass Index between 18-32